Thierry P P van den Bosch
Overview
Explore the profile of Thierry P P van den Bosch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
619
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stavrakaki E, Belcaid Z, Balvers R, Vogelezang L, van den Bossche W, Alderliesten D, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002198
: Access to high-quality patient-derived brain tumor tissues is instrumental for translational neuro-oncology research. Glioblastoma tumor material resected by ultrasonic aspiration (UA) during surgery offers an abundant source of material;...
2.
Kraaijeveld R, Hesselink D, Dieterich M, van den Bosch T, Heidt S, Baan C
Hum Immunol
. 2025 Feb;
86(2):111242.
PMID: 39903994
B cell responses are dependent on specialized help provided by follicular T helper (Tfh). Tfh and B cells both express the transcription factor B-cell lymphoma 6 protein (BCL6) and targeting...
3.
Scholtes M, Akbarzadeh M, Galaras A, Nakauma-Gonzales J, Bazrafshan A, Solanki V, et al.
Cancer Lett
. 2025 Feb;
614:217506.
PMID: 39892702
Somatic mutations in ARID1A (AT-rich interactive domain-containing protein 1A) are present in approximately 25 % of bladder cancers (BC) and are associated with poor prognosis. With a view to discover...
4.
Rijstenberg L, Harikumar H, Verhoef E, van den Bosch T, Choiniere R, van Royen M, et al.
Histopathology
. 2025 Jan;
PMID: 39888049
Aims: Intraductal carcinoma (IDC) is an independent pathological parameter for adverse prostate cancer (PCa) outcome. Although most IDC are believed to originate from retrograde spread of established PCa, rare IDC...
5.
Ntafoulis I, Koolen S, van Tellingen O, den Hollander C, Sabel-Goedknegt H, Dijkhuizen S, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770529
Background: Glioblastoma is an aggressive and incurable type of brain cancer. Little progress has been made in the development of effective new therapies in the past decades. The blood-brain barrier...
6.
Windster J, Windster J, Kakiailatu N, Kakiailatu N, Kuil L, Kuil L, et al.
Gastroenterology
. 2024 Dec;
PMID: 39725172
Background & Aims: The enteric nervous system (ENS), which is composed of neurons and glia, regulates intestinal motility. Hirschsprung disease (HSCR) results from defects in ENS formation; however, although neuronal...
7.
Leunissen D, Moonen L, von der Thusen J, den Bakker M, Hillen L, van Weert T, et al.
J Thorac Oncol
. 2024 Nov;
PMID: 39581377
Introduction: Multi-omic studies have identified three molecular separated pulmonary carcinoid (PC) subgroups (A1, A2, B) with distinctive mRNA expression profiles (e.g., orthopedia homeobox protein [OTP], achaete-scute homolog [ASCL1], and hepatocyte...
8.
Nguyen J, Drabarek W, Leeflang A, Brands T, van den Bosch T, Verdijk R, et al.
Invest Ophthalmol Vis Sci
. 2024 Oct;
65(12):11.
PMID: 39374010
Purpose: Unfortunately, treatment of patients with uveal melanoma (UM) with metastatic disease is limited. Twenty percent of patients with UM harbor a mutation in the splicing factor gene SF3B1, suggesting...
9.
van Stigt A, von der Thusen J, Mustafa D, van den Bosch T, Lila K, Vadgama D, et al.
J Clin Immunol
. 2024 Oct;
45(1):22.
PMID: 39373788
Granulomatous disease affects up to 20% of patients with Common Variable Immunodeficiency (CVID). Granulomas are comprised of highly activated immune cells, and emerge in response to antigenic triggers. In CVID...
10.
van Baardwijk M, Wagenmakers A, van den Bosch T, Hesselink D, Loupy A, Kramann R, et al.
Nephrol Dial Transplant
. 2024 Aug;
40(2):224-226.
PMID: 39215437
No abstract available.